Atovaquone Oral Suspension
1 NDC across 1 manufacturer|1 Generic,0 Brand
Atovaquone Oral Suspension is used to treat pneumocystis pneumonia and cerebral toxoplasmosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Atovaquone Oral Suspension is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.76 to $0.76 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$0.76 – $0.76
per ML
7d Activity
avg +10.5% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ATOVAQUONE ORAL SUSPENSION
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ATOVAQUONE 750 MG/5 ML SUSP CUP | $0.7561 per ML | +10.51% |
Frequently Asked Questions
What is Atovaquone Oral Suspension used to treat?
Atovaquone Oral Suspension is used to treat pneumocystis pneumonia and cerebral toxoplasmosis, per the National Library of Medicine's MED-RT classification.
How many Atovaquone Oral Suspension products are on the market?
The Atovaquone Oral Suspension drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Atovaquone Oral Suspension?
NADAC reference prices for Atovaquone Oral Suspension range from $0.7561 to $0.7561 per ML.
Which manufacturers make Atovaquone Oral Suspension?
1 manufacturer lists Atovaquone Oral Suspension in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (1).
How has the price of Atovaquone Oral Suspension changed recently?
Over the past 7 days, 2 Atovaquone Oral Suspension NDCs rose and 0 fell, with a market-wide average change of +10.5%.